Important: New Login Process

We've updated our access and security system. The first time you log in, enter your work email, and we'll guide you through the process.

  • If your organization uses Single Sign-On (SSO), you will be redirected to your company's login portal.
  • If you log in with a username and password, you will be prompted to set a new password before accessing your account.

Go to the Login Page to get started.

We appreciate your cooperation during this transition. If you need assistance, please call +1 650-552-4224 or email support@biocentury.com.

BioCentury
  • Company Profiles
  • Target Profiles
  • Product Profiles
Explore BCIQ profiles by entering a company name.

Ilypsa Inc.

Headquarters: Santa Clara, CA, United States of America
Website: N/A
Year Founded: 2003
Status: Acquired

BioCentury | Jun 28, 2018
Financial News

Tricida gains, others dip after upsized IPOs

BioCentury | Jun 5, 2018
Financial News

Tricida files for $150M IPO

BioCentury | Oct 10, 2016
Clinical News

Kiklin bixalomer regulatory update

BioCentury | Aug 1, 2016
Finance

Tricida: Ilypsa 3.0?

How CKD play Tricida could be following the Relypsa/Ilypsa game plan
BioCentury | May 30, 2016
Finance

It takes a village

How VC 5AM will avoid strikeouts with its new early stage biotech fund
BioCentury | Apr 18, 2016
Finance

Double-dipping

How rumored Relypsa takeout could add to 5AM's returns
BioCentury | Mar 7, 2016
Clinical News

Kiklin bixalomer regulatory update

BioCentury | Oct 12, 2015
Clinical News

Kiklin bixalomer regulatory update

BioCentury | Oct 15, 2012
Product Development

Gut instinct

Ardelyx lands first partner as AstraZeneca moves into diabetic complications
Items per page:
1 - 10 of 30